Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014.

PMID: 28093943 ·

V, i, n, a, y, , K, , R, a, t, h, i, ;, , B, o, , W, a, n, g, ;, , J, o, s, e, p, h, , S, , R, o, s, s, ;, , N, i, c, h, o, l, a, s, , S, , D, o, w, n, i, n, g, ;, , A, a, r, o, n, , S, , K, e, s, s, e, l, h, e, i, m, ;, , S, t, a, c, e, y, , T, , G, r, a, y

RevistaOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Ano
PMID28093943

Resumo

The US Food and Drug Administration (FDA) approves high-risk medical devices based on premarket pivotal clinical studies demonstrating reasonable assurance of safety and effectiveness and may require postapproval studies (PAS) to further inform benefit-risk assessment. We conducted a cross-sectional analysis using publicly available FDA documents to characterize industry-sponsored pivotal studies and PAS of high-risk devices used in the treatment of otolaryngologic diseases. Between 2000 and 201

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑